Non steroidal anti-inflammatory drugs and colorectal cancer: is there a way forward?

This publication has 65 references indexed in Scilit:

• Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin☆☆☆
  Gastroenterology, 1998
• 717: Influence of low dose sullndac on p53 proteins, on BCL-2 protein and on TGFα in rectal mucosa biopsies of cancer prone patients (FAP) in a chemopreventive trial
  European Journal Of Cancer, 1997
• Sulindac sulfide inhibits the proliferation of colon cancer cells: diminished expression of the proliferation markers PCNA and Ki-67
  Cancer Letters, 1997
• CYCLOOXYGENASE-2 INHIBITORS: A New Class of Anti-Inflammatory Agents That Spare the Gastrointestinal Tract
  Gastroenterology Clinics of North America, 1996
• NSAID USE AND DECREASED RISK OF GASTROINTESTINAL CANCERS
  Gastroenterology Clinics of North America, 1996
• SHORT COMMUNICATION: Sulindac suppresses tumorigenesis in the Min mouse
  Carcinogenesis: Integrative Cancer Research, 1996
• Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
• Nonsteroidal antiinflammatory agents in chemoprevention of colorectal cancer at what cost?
  Digestive Diseases and Sciences, 1994
• Low-Dose Aspirin and Incidence of Colorectal Tumors in a Randomized Trial
  JNCI Journal of the National Cancer Institute, 1993
• APC mutations occur early during colorectal tumorigenesis
  Nature, 1992